EXPLORATION OF HYDROXYL SUBSTITUTED REGORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA THROUGH MOLECULAR DOCKING. (2026). Frontier in Medical and Health Research, 4(3), 3863-3874. https://fmhr.net/index.php/fmhr/article/view/3740